Takagishi K, Yamamoto M, Miyahara H, Hotokebuchi T, Kaibara N
Department of Orthopedic Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.
Agents Actions. 1992 Nov;37(3-4):284-9. doi: 10.1007/BF02028121.
The effects of the immunosuppressive agents cyclosporin G (CsG) and cyclosporin A (CsA) on collagen arthritis were compared in mice. When administered subcutaneously daily on days 0-13 after immunization with type II collagen, CsG and CsA were both capable of suppressing the development of collagen arthritis in mice as well as the immunological response to native type II collagen in a dose-dependent manner. Histopathologically, no marked inflammatory lesions were observed in diarthroidal joints from mice treated with 100 mg/kg per day of CsA or 800 mg/kg per day of CsG. However, an analysis of dose response showed CsG to be 8 times less potent than CsA in inhibiting the development of arthritis.
在小鼠中比较了免疫抑制剂环孢菌素G(CsG)和环孢菌素A(CsA)对胶原性关节炎的影响。在用II型胶原免疫后的第0 - 13天每天皮下给药,CsG和CsA均能够以剂量依赖的方式抑制小鼠胶原性关节炎的发展以及对天然II型胶原的免疫反应。组织病理学上,在每天接受100 mg/kg CsA或800 mg/kg CsG治疗的小鼠的滑膜关节中未观察到明显的炎性病变。然而,剂量反应分析表明,在抑制关节炎发展方面,CsG的效力比CsA低8倍。